Trivalent HBV Vaccine Superior in Efficacy in Adults 45 Years and Older

A Phase III study has found a trivalent hepatitis B virus (HBV) vaccine demonstrated superiority in adults 45 years and older and noninferior in adults older than 18 years compared with a monovalent vaccine.
Study Finds Safe Treatment for Children with Severe Hemophilia A with Inhibitors

Researchers have found combining immune tolerance induction (ITI) with Hemlibra (emicizumab, Roche) is a feasible and safe way of treating children with severe hemophilia A.
Flu Vaccine May Reduce Risk of Heart Attack and Stroke in Hypertensive Individuals

A new study shows cardiovascular outcomes may improve in individuals with hypertension if they receive the influenza (flu) vaccine during the flu season.
Skin Patch Shows Promise for Delivery of Influenza Vaccine

Researchers at the University of Rochester Medical Center in New York City have developed a new type of skin patch that could replace needles as a method to deliver the influenza (flu) vaccine.
FDA Expands Indication for Octapharma’s WILATE to Hemophilia A

The U.S. Food and Drug Administration (FDA) has approved WILATE for treatment of adults and adolescents with hemophilia A for routine prophylaxis.
Researchers Uncover How Human Immunity Evades Influenza Virus

A new study that looked at how the influenza (flu) virus escapes antibodies found the site of the escape mutation varies among most individuals’ sera.
FDA Approves Sandoz’s Ziextenzo as 24th Biosimilar

The U.S. Food and Drug Administration (FDA) has approved Ziextenzo (pegfilgrastim-bmez), the 24th biosimilar approval in the U.S.
CMS Launches Healthy Adult Opportunity Demonstration Initiative

The Centers for Medicare and Medicaid Services (CMS) has launched the Healthy Adult Opportunity (HAO) optional demonstration initiative to give states tools to design innovative health coverage programs for adult beneficiaries, while holding states accountable for results and maintaining strong protections for the most at-risk populations.
Medicare Will Now Cover Acupuncture for Chronic Low Back Pain

The Centers for Medicare and Medicaid Services (CMS) finalized a decision to cover acupuncture for Medicare patients with chronic low back pain.
Finalized Health Care Price Transparency Rule Unveiled

New rule requires hospitals to share previously obscured price information, including discounts for cash-paying patients and rates negotiated with insurers.